2008
DOI: 10.1016/j.jtcvs.2008.04.014
|View full text |Cite
|
Sign up to set email alerts
|

A prospective randomized trial comparing completion technique of fissures for lobectomy: Stapler versus precision dissection and sealant

Abstract: The use of electrocautery dissection and collagen patches coated with human fibrinogen and thrombin (TachoSil, Nycomed, Vienna, Austria) for aerostasis to complete interlobar fissures seems to be safe and effective in reducing alveolar air leaks and procedure costs. Although this pilot study showed advantages in terms of hospitalization and cost benefits, further multicentric studies are required to clarify that these differences are statistically significant.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
38
0
2

Year Published

2009
2009
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 49 publications
(42 citation statements)
references
References 27 publications
0
38
0
2
Order By: Relevance
“…The incidence of prolonged air leak (PAL) is a common complication after pulmonary major surgeries, which incidences reported 7.6-10% in several studies (1)(2)(3)(4).…”
Section: Introductionmentioning
confidence: 99%
“…The incidence of prolonged air leak (PAL) is a common complication after pulmonary major surgeries, which incidences reported 7.6-10% in several studies (1)(2)(3)(4).…”
Section: Introductionmentioning
confidence: 99%
“…19 In recent years, TachoSil (Takeda Pharma), a ready-to-use, fixed combination of a collagen sponge coated with a dry layer of the biologically active human coagulation factors fibrinogen and thrombin, was introduced into the market and was used mainly as a hemostatic agent in visceral, thoracic, gynecological, and urological surgery. 9,13,16,17,[29][30][31] In liver surgery, TachoSil was superior to argon-beam laser hemostasis in a controlled parallel group trial. 13 Several animal studies could prove a beneficial effect of TachoSil in hemostasis compared with other sealant techniques.…”
mentioning
confidence: 99%
“…Eight (53%) of the 15 studies showed a statistically significant difference in favour of TachoSil. Further, two randomized controlled trials showed that use of TachoSil in pulmonary surgery generated savings in the range of 98.00–205.50 Euros per patient when compared with standard techniques 22,23…”
Section: Resultsmentioning
confidence: 99%